Aurora Spine Reports 4Q18 Revenue of $2.5MM, +82.4% vs. 4Q17

by Mike Evers on April 29, 2019

Aurora Spine reported 4Q18 revenue of USD $2.5MM, +82.4% vs. 4Q17, with full-year 2018 revenue of $8.7MM, +44.5% vs. 2017.

Record year, with highest revenue in company’s history
Integrated more products into Screwless Procedure, a surgical approach to spinal fusion that includes ZIP MIS Fusion Systems, TiNano Interbody cages and...

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

	4Q18	4Q17	$ Chg	% Chg
Spine	$2.3	$1.3	$1.1	81.5%
Orthobiologics	$0.1	$0.1	$0.1	99.0%
Total	$2.5	$1.4	$1.1	82.4%

	FY18	FY17	$ Chg	% Chg
Spine	$8.2	$5.7	$2.5	43.7%
Orthobiologics	$0.5	$0.3	$0.2	57.6%
Total	$8.7	$6.0	$2.7	44.5%

FY18	Amount ($MM)	% of Sales
Sales	$8.7
Cost of Sales	-$4.1	47.1%
General and Admin	-$2.9	33.1%
Marketing	$0.0	0.5%
R & D	$0.0	0.4%
Other	-$1.7	19.6%
Net Earnings	-$0.1	-0.8%

	4Q18	4Q17	$ Chg	% Chg
Spine	$2.3	$1.3	$1.1	81.5%
Orthobiologics	$0.1	$0.1	$0.1	99.0%
Total	$2.5	$1.4	$1.1	82.4%

	FY18	FY17	$ Chg	% Chg
Spine	$8.2	$5.7	$2.5	43.7%
Orthobiologics	$0.5	$0.3	$0.2	57.6%
Total	$8.7	$6.0	$2.7	44.5%

Aurora Spine Reports 4Q18 Revenue of $2.5MM, +82.4% vs. 4Q17

Orthopedic Market Faces Stiffer Test in Third Quarter 2023

DePuy Synthes Aims to Improve Operations with Ortho Restructure

OrthoPediatrics Sees Opportunity to Claim Dominant Share Position

Vericel Extends Growth Streak, Preps for Arthroscopic MACI

Orthofix Fundamentals and Merger Thesis Remain Intact

Get the ORTHOWORLD Newsletter!

Contact Us